PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 120 filers reported holding PARATEK PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is 0.41 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $82,190 | -84.8% | 43,952 | -60.6% | 0.00% | -100.0% |
| Q3 2021 | $542,000 | -68.4% | 111,547 | -55.7% | 0.00% | -75.0% |
| Q2 2021 | $1,716,000 | +952.8% | 251,598 | +520.9% | 0.01% | +700.0% |
| Q4 2019 | $163,000 | -81.1% | 40,522 | -15.9% | 0.00% | -97.2% |
| Q4 2017 | $862,000 | -21.6% | 48,160 | +9.5% | 0.04% | -29.4% |
| Q3 2017 | $1,100,000 | +16.8% | 43,987 | +12.1% | 0.05% | +24.4% |
| Q2 2017 | $942,000 | – | 39,238 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $10,480,000 | 3.34% |
| Roumell Asset Management, LLC | 340,323 | $1,372,000 | 3.14% |
| Abingworth LLP | 1,041,131 | $4,185,000 | 2.02% |
| ICM ASSET MANAGEMENT INC/WA | 448,315 | $1,807,000 | 1.48% |
| Trellus Management Company, LLC | 147,055 | $593,000 | 0.99% |
| Prosight Management, LP | 450,000 | $1,814,000 | 0.80% |
| ARMISTICE CAPITAL, LLC | 2,268,000 | $9,140,000 | 0.53% |
| Arbiter Partners Capital Management LLC | 848,069 | $3,418,000 | 0.50% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 966,493 | $3,895,000 | 0.30% |
| GENERAL AMERICAN INVESTORS CO INC | 644,323 | $2,597,000 | 0.24% |